Published in Thorax on October 01, 1992
Suspected acute pulmonary embolism: a practical approach. British Thoracic Society, Standards of Care Committee. Thorax (1997) 3.59
Management of pulmonary embolism. Thorax (1993) 0.75
Management of pulmonary embolism. Thorax (1993) 0.75
Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet (1960) 7.96
The value of the autopsy in three medical eras. N Engl J Med (1983) 7.00
Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med (1988) 5.81
Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ (1991) 3.14
The post-mortem incdence of pulmonary embolism in a hospital population. Br J Surg (1968) 2.66
FREQUENCY OF PULMONARY THROMBOEMBOLISM IN MAN. N Engl J Med (1965) 2.14
Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism. Br Med J (1971) 2.06
Venous thromboembolism. Am Rev Respir Dis (1990) 2.06
Obstetric complications associated with the lupus anticoagulant. N Engl J Med (1985) 2.05
Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolism. Lancet (1991) 1.99
Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolism. Chest (1985) 1.92
Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis. Lancet (1992) 1.73
A study of pulmonary embolism. III. The mechanism of pain; based on a clinicopathological investigation of 100 cases of minor and 100 cases of massive embolism of the pulmonary artery. Arch Intern Med (1961) 1.60
Deep venous thrombosis and pulmonary embolism: prediction, prevention and treatment. Am J Cardiol (1959) 1.57
The relationship between lupus anticoagulants and antibodies to phospholipid. JAMA (1988) 1.50
Heparin kinetics in venous thrombosis and pulmonary embolism. Circulation (1976) 1.50
The electrocardiogram in acute pulmonary embolism. Prog Cardiovasc Dis (1975) 1.46
COMPLETE RESOLUTION OF MASSIVE PULMONARY THROMBOEMBOLISM. JAMA (1964) 1.46
The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level. Ann Intern Med (1987) 1.42
Lung scintigraphy--doubt and certainty in the diagnosis of pulmonary embolism. Clin Radiol (1989) 1.40
Long-term prognosis of treated acute massive pulmonary embolism. Br Heart J (1977) 1.37
Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonay embolism. Br Med J (1974) 1.35
Current status of pulmonary thromboembolic disease: pathophysiology, diagnosis, prevention, and treatment. Am Heart J (1982) 1.34
Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy. Am J Med (1987) 1.29
Pulmonary embolectomy: a 25 year experience. J Thorac Cardiovasc Surg (1986) 1.21
Acute pulmonary embolism treated with tissue plasminogen activator. Lancet (1986) 1.06
Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med (1984) 1.06
Quantitative two-dimensional echocardiography in massive pulmonary embolism: emphasis on ventricular interdependence and leftward septal displacement. J Am Coll Cardiol (1987) 1.05
Diagnosis and management of pulmonary thromboembolism. Q J Med (1990) 1.02
Massive pulmonary embolism. Am J Surg (1973) 1.01
Physician practices in the treatment of pulmonary embolism and deep venous thrombosis. Arch Intern Med (1988) 0.98
Determination of systemic vascular resistance by a noninvasive technic. Circulation (1973) 0.97
Pulmonary embolectomy for acute massive pulmonary embolism: an analysis of 71 cases. Br Heart J (1988) 0.92
Natural course of treated pulmonary embolism. Evaluation by perfusion lung scintigraphy, gas exchange, and chest roentgenogram. Chest (1990) 0.91
Management of venous thromboembolism. Lancet (1988) 0.90
Pulmonary angiography in severe chronic pulmonary hypertension. Ann Intern Med (1987) 0.88
Venous thrombosis in a family with defective release of vascular plasminogen activator and elevated plasma factor VIII/von Willebrand's factor. Am J Med (1983) 0.86
Ventricular interaction during experimental acute pulmonary embolism. Circulation (1988) 0.82
The dead space to tidal volume ratio in the diagnosis of pulmonary embolism. Am Rev Respir Dis (1986) 0.82
Release of tissue plasminogen activator and its fast-acting inhibitor in defective fibrinolysis. Arch Intern Med (1986) 0.82
Surgical approaches to thromboembolism. Br J Surg (1984) 0.81
Pulmonary embolism: current therapeutic concepts. Drugs (1976) 0.80
Indium-111 platelet scintigraphy for the diagnosis of acute venous thrombosis. Circulation (1986) 0.80
Usefulness of noninvasive diagnostic tools for diagnosis of acute pulmonary embolism in patients with a normal chest radiograph. Am J Cardiol (1991) 0.80
Pulmonary embolectomy: a review. Can J Surg (1985) 0.79
Comparison of fibrinolytic treatment with interruption of the inferior caval vein in the prevention of pulmonary embolism. Int J Cardiol (1986) 0.79
Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times. Am J Med (1990) 0.78
Computed tomography of pulmonary thromboembolism and infarction. J Comput Assist Tomogr (1988) 0.78
Pulmonary embolectomy: its place in the management of pulmonary embolism. Lancet (1988) 0.77
Heparin-induced thrombosis (white clot syndrome) secondary to prophylactic subcutaneous administration of heparin. Can J Surg (1988) 0.77
Deep vein thrombosis: scintigraphic diagnosis with In-111-labeled monoclonal antifibrin antibodies. Radiology (1989) 0.77
Low incidence of thrombocytopenia with porcine mucosal heparin. A prospective multicenter study. Arch Intern Med (1989) 0.77
Pulmonary digital subtraction angiography. Radiol Clin North Am (1985) 0.77
Pulmonary embolism death rates. Am Heart J (1988) 0.77
Diagnostic modalities for detection of pulmonary embolism in clinical routine: a European survey. Lung (1990) 0.76
Acute pulmonary embolism: diagnostic value of digital subtraction angiography. Radiology (1988) 0.76
Pulmonary artery thrombus detection by magnetic resonance imaging. Chest (1989) 0.76
Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation (1998) 5.93
Basis for detection of stenosis using venous administration of microbubbles during myocardial contrast echocardiography: bolus or continuous infusion? J Am Coll Cardiol (1998) 1.19
Haemorrhagic cystitis and renal dysfunction associated with high dose benzylpenicillin. J Infect (2000) 0.90
Prescription of regular aspirin in patients with chest pain referred to a cardiology outpatient clinic. BMJ (1995) 0.88
Fascicular tachycardia: uncommon or just unrecognised? Emerg Med J (2002) 0.85
Three-dimensional myocardial contrast echocardiography: validation of in vivo risk and infarct volumes. J Am Coll Cardiol (1997) 0.80
Application of coronary angiography in the UK: disease severity or physician preference? QJM (1995) 0.75
Non-invasive assessment of myocardial blood flow using echocardiography. Int J Cardiol (2000) 0.75